MedPath

Trilogy Comparison Study - Adults

Not Applicable
Completed
Conditions
Respiratory Insufficiency
Respiratory Failure
Interventions
Device: Trilogy
Device: Standard of Care
Registration Number
NCT00810498
Lead Sponsor
Philips Respironics
Brief Summary

The objective of this study (Part II) will be to compare the performance of the Trilogy device and a conventional ventilator (participant's current device). Both devices will be set to the participants' current mode and prescription settings.

Detailed Description

A. Primary Hypothesis and end-point In patients with respiratory insufficiency, when compared to conventional ventilators, the Trilogy device achieves comparable level of gas exchange (measured as partial pressure of CO2 in arterial or venous blood)and SpO2 levels during various modes of ventilation.

B. Secondary Hypothesis and end-points In patients with respiratory insufficiency, when compared to conventional ventilators, the Trilogy device achieves comparable breathing pattern (tidal volume, respiratory rate, minute ventilation), hemodynamics (heart rate), and subjective measures of breathing comfort (measured by modified Borg dyspnea scale).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  1. Age > 21 years of age; < 85 years of age
  2. Able to follow instructions
  3. Able to provide informed consent
  4. Considered clinically stable, with low flow oxygen requirements less than 15 LPM (or FIO2 less than 60 %) and PEEP no greater than 10 cm H2O.
  5. Requiring mechanical ventilation through nasal/facial mask,tracheostomy or endotracheal tube (ET Tube)
Exclusion Criteria
  1. Clinically unstable, i.e.,

    1. Acute Respiratory Failure
    2. Participants with refractory hypotension defined as systolic blood pressure less than 90 mm Hg despite inotropic agents),
    3. Uncontrolled cardiac ischemia or arrhythmias,
    4. or as otherwise determined inappropriate for the study as determined by the investigator.
  2. Patients suffering from metastatic or terminal cancer and patients with do-not-resuscitate orders

  3. Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
TrilogyTrilogyTrilogy Device
Standard of CareStandard of CareParticipants prescribed ventilator
Primary Outcome Measures
NameTimeMethod
Comparable Level of Gas Exchange (Measured as Partial Pressure of CO2 in Arterial or Venous Blood).After one hour of ventilator use

Blood gas was obtained for this study one hour after use of each device.

Comparable Level of Gas Exchange SpO2 Levels During Various Modes of Ventilation.After one hour of ventilator use

Pulse Oximetry was measured after one hour of use of each ventilator.

Secondary Outcome Measures
NameTimeMethod
Tidal VolumeOne hour during ventilator use.

Tidal volume is the amount of air that moves in or out of the lungs with each respiratory cycle. It measures around 500 mL in an average healthy adult male and approximately 400 mL in a healthy female. Average tidal volume was compare after a hour of use of each device.

Minute VentilationOne hour during ventilator use.

Minute ventilation is the volume of gas inhaled or exhaled from a person's lungs per minute. This was measured after one hour of use of each device.

Hemodynamics (Heart Rate)One hour during ventilator use.

Number of beats per minute. Measured after one hour of use of each device.

Trial Locations

Locations (1)

University of Manitoba

🇨🇦

Winnipeg, Manitoba, Canada

© Copyright 2025. All Rights Reserved by MedPath